Human FABP5 knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
FABP5 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 22 bp deletion in exon2 and 2 bp deletion in exon2.
View Alternative Names
CFABP, Cutaneous fatty acid binding protein, DA11, Differentiation associated lipid binding protein LP2, E-FABP, Epidermal-type fatty acid-binding protein, FABP5_HUMAN, Fatty acid binding protein epidermal, Fatty acid-binding protein 5, KFABP, Keratinocyte lipid binding protein, Klbp, PA-FABP, Psoriasis-associated fatty acid-binding protein homolog, fatty acid binding protein 5 (psoriasis-associated)
- WB
Unknown
Western blot - Human FABP5 knockout HeLa cell lysate (AB257431)
Lane 1 : Wild-type HeLa cell lysate (20 ug)
Lane 2 : FABP5 knockout HeLa cell lysate (20 ug)
Lane 3 : PC-3 cell lysate (20 ug)
ab84028 was shown to specifically react with FABP5 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265905 (knockout cell lysate ab257431) was used. Wild-type and FABP5 knockout samples were subjected to SDS-PAGE. ab84028 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2.5 hours at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FABP5 antibody (<a href='/en-us/products/primary-antibodies/fabp5-antibody-ab84028'>ab84028</a>) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FABP5 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FABP5 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fabp5-knockout-hela-cell-line-ab265905'>ab265905</a>)
Lane 3:
PC-3 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 15 kDa
Observed band size: 17 kDa
false
- WB
Supplier Data
Western blot - Human FABP5 knockout HeLa cell lysate (AB257431)
Lanes 1-3 : Merged signal (red and green). Green - ab255276 observed at 17 kDa. Red - loading control ab8245 observed at 36 kDa.
ab255276 Anti-FABP5 antibody [EPR22552-64] was shown to specifically react with FABP5 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265905 (knockout cell lysate ab257431) was used. Wild-type and FABP5 knockout samples were subjected to SDS-PAGE. ab255276 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2.5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FABP5 antibody [EPR22552-64] (<a href='/en-us/products/primary-antibodies/fabp5-antibody-epr22552-64-ab255276'>ab255276</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FABP5 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FABP5 knockout HeLa cell lysate (ab257431)
Lane 2:
Western blot - Human FABP5 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fabp5-knockout-hela-cell-line-ab265905'>ab265905</a>)
Lane 3:
PC-3 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Observed band size: 17 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human FABP5 knockout HeLa cell lysate (AB257431)
Allele-1 : 22 bp deletion in exon2
- Sanger seq
Unknown
Sanger Sequencing - Human FABP5 knockout HeLa cell lysate (AB257431)
Allele-2 : 2 bp deletion in exon2
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FABP5 interacts with specific ligands such as long-chain fatty acids which influences cellular processes like growth differentiation and energy homeostasis. It is not known to be part of a larger complex. This protein is integral in regulating lipid signaling pathways and responses due to its binding capacity which modulates the availability of fatty acids for metabolic processes. Its expression pattern hints at a possible role in the body's adaptation to dietary lipid intake.
Pathways
FABP5 holds a significant position in the peroxisome proliferator-activated receptor (PPAR) signaling pathway and the fatty acid metabolism pathway. In the PPAR signaling pathway FABP5 influences the activity of PPARβ/δ receptors which regulate gene expression involved in lipid metabolism and energy homeostasis. It is related to other fatty acid binding proteins such as FABP4 which similarly participate in lipid metabolic processes and have roles in the regulation of lipid and glucose metabolism.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com